Asan Medical Center, Univ. of Ulsan

Seoul 05505

2 studies enrolling now · 2 studies all time

What they study most

Endometrial Cancer, Fallopian Tube Cancer, Low-grade Serous Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Cancer, Recurrent Endometrial Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Cancer, Recurrent Primary Peritoneal Cancer

Studies at this site

• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers — Recruiting now
• Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer — Recruiting now